KRAS and lung adenocarcinoma: In murine models of mutant Kras-driven lung adenocarcinoma, tumorigenesis was dependent on Tregs, and Kras transgenic mice that were deficient in FoxP3+ Tregs developed 75% fewer lung tumors than wild-type mice [59].